Renal Business Today

Vascular Access

Lifeline Launches Network for Physician Communication

VERNON HILLS, Ill.—Lifeline Vascular Access has launched an integrated network to allow physicians to share clinical practices, patient outcomes and financial data ...More
August 12, 2009
Posted in News, Business, Clinical & Pharma, Practice Management
American Vascular Access Names New Clinical Services Director, VP Business Development

DUNEDIN, Fla.—American Vascular Access has named Maxine M. Mann, BSN, MA, CNN, to be its director of clinical services, and has hired David R. Prather, MBA, to be its vice president of business development. ...More
July 22, 2009
Posted in News, Business, Practice Management
Medisystems Extends Needle Agreement with Fenwal

LAWRENCE, Mass.—Medisystems, which is a subsidiary of NxStage Medical, said July 21 that it has agreed to a three-year contract extension to supply Fenwal Inc. with needle sets and assemblies. ...More
July 21, 2009
Posted in News, Business, Clinical & Pharma, Government & Regulation
Crit-Line Available in Aquadex FlexFlow Device

SALT LAKECITY—Hema Metrics and CHF Solutions announced June 30 that the Hema Metrics Crit-Line technology is now available in the Aquadex FlexFlow device manufactured by CHF Solutions Inc. ...More
June 30, 2009
Posted in News, Business, Clinical & Pharma
Vascular Devices and Biofilm: Webinar Opportunity

BOZEMAN, Mont.—The free, live Webinar, “Why are Vascular Devices Prone to Biofilm Contamination?” will be presented on http://www.TargetBSI.com and will address the emerging issue of biofilms. ...More
June 25, 2009
Posted in News, Business, Clinical & Pharma, Government & Regulation, Practice Management
NxStage, Gambro Ink Bloodline Distribution Agreement

NxStage Medical, Inc. announced a 5-year U.S. distribution agreement between its subsidiary, Medisystems Corporation, and Gambro, in which Medisystems will supply blood tubing sets, including the ReadySet® and the Streamline® to Gambro. In turn, Gambro will exclusively ...More
June 17, 2009
Posted in News, Business, Clinical & Pharma
Expensive Diabetes Treatments Put Under Microscope

A recent Wall Street Journal article examined a study sponsored by National Institutes of Health and several drugmakers that revealed that aggressive use of expensive diabetes drugs and medical devices called stents did no better than cheaper treatments at preventing ...More
June 8, 2009
Posted in News, Clinical & Pharma, Government & Regulation
Surviving Future Vascular Access Reimbursement Reductions

Beginning in 2007, vascular access reimbursement rates have experienced significant reduction with more proposed in 2010. ...More
June 2, 2009
Posted in Articles, Business, Clinical & Pharma, Government & Regulation, Practice Management
Aspirin, Anti-Clotting Drug Combo Lowers Dialysis Access Failure

WASHINGTON—The combination of aspirin and an anti-clotting drug reduces risk of dialysis access failure, according to a study in the May 21 issue of the New England Journal of Medicine. ...More
May 21, 2009
Posted in News, Clinical & Pharma
Pervasis’ Vascular Access Drug Gets Orphan Drug Designation

CAMBRIDGE, Mass.—The U.S. Food and Drug Administration has given orphan drug designation to Pervasis Therapeutic’s vascular access drug Vascugel. ...More
May 5, 2009
Posted in News, Clinical & Pharma, Government & Regulation